DMD (DMD-exon 7) Antisense Oligonucleotide, aDMD.Oligo2

  • Check with publisher
  • Published date: December 30, 2020
    • United States

The product Cat#ASO-GT0006WQ is antisense oligonucleotide targeting DMD-exon 7, which is able to to induce consistent skipping of the target exon. This ASO product has the ability to influence RNA processing and modulate protein expression, whcih can be used in the Duchenne muscular dystrophy research.
https://www.creative-biolabs.com/gene-therapy/admd-oligo2-12165.htm

Result 0 votes
Jerry Carter
1 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • DMD (DMD-exon 8) Antisense Oligonucleotide, aDMD.Oligo1

    DMD (DMD-exon 8) Antisense Oligonucleotide, aDMD.Oligo1

    Cell Biology & Microbiology (United States ) December 30, 2020 Check with publisher

    The product Cat#ASO-GT0005WQ is antisense oligonucleotide targeting DMD-exon 8, which is able to to induce consistent skipping of the target exon. This ASO product has the ability to influence RNA processing and modulate protein expression, whcih can...

  • CYP19A1 (CYP19A1-exon 2) Antisense Oligonucleotide, aCYP19A1.Oligo1

    CYP19A1 (CYP19A1-exon 2) Antisense Oligonucleotide, aCYP19A1.Oligo1

    Cell Biology & Microbiology (United States ) December 30, 2020 Check with publisher

    The product Cat#ASO-GT0004WQ is antisense oligonucleotide targeting CYP19A1-exon 2, which is able to inhibit the expression of aromatase. This ASO product has the ability to influence RNA processing and modulate protein expression, whcih can be used ...

  • BCR-ABL (BCR-exon 3/ABL-exon 2) Antisense Oligonucleotide, aBCR-ABL.Oligo3

    BCR-ABL (BCR-exon 3/ABL-exon 2) Antisense Oligonucleotide, aBCR-ABL.Oligo3

    Cell Biology & Microbiology (United States ) December 30, 2020 Check with publisher

    The product Cat#ASO-GT0003WQ is antisense oligonucleotide targeting BCR-exon 3/ABL-exon 2, which is able to inhibit the growth of leukemic cells. This ASO product has the ability to influence RNA processing and modulate protein expression, whcih can ...